Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Irish EUR

Uniphar plc (UPR.IR)

Compare
2.7335
-0.0555
(-1.99%)
As of 1:10:59 PM GMT+1. Market Open.
Loading Chart for UPR.IR
  • Previous Close 2.7890
  • Open 2.7405
  • Bid 2.7205 x --
  • Ask 2.7370 x --
  • Day's Range 2.7040 - 2.7405
  • 52 Week Range 1.9040 - 2.8215
  • Volume 28,686
  • Avg. Volume 612,793
  • Market Cap (intraday) 709.546M
  • Beta (5Y Monthly) 0.98
  • PE Ratio (TTM) 11.39
  • EPS (TTM) 0.2400
  • Earnings Date Feb 25, 2025
  • Forward Dividend & Yield 0.02 (0.69%)
  • Ex-Dividend Date Apr 24, 2025
  • 1y Target Est 4.61

Uniphar plc, together with its subsidiaries, operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, the Netherlands, and internationally. It operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. The company provides sales, marketing, compliance, and distribution services to medical device manufacturers; high-value services across the life cycle of a pharmaceutical product; and healthcare professionals with access to medicines that cannot source through traditional channels. It is also involved in the pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals and veterinary surgeons; operates a network of pharmacies under the Life, Allcare, Hickey's, and McCauley brands. In addition, the company provides pharmacy support, pharmaceutical supply chain and services, medical device distribution, specialist nursing and infusion, outsourcing and resourcing, healthcare technology, medical affairs, online pharmacy and product fostering, and telecommunications support services, as well as specialist provider of pharmaceuticals. Uniphar plc was founded in 1967 and is headquartered in Dublin, Ireland.

www.uniphar.ie

3,500

Full Time Employees

December 31

Fiscal Year Ends

Recent News: UPR.IR

View More

Performance Overview: UPR.IR

Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is ISEQ All Share (^ISEQ) .

YTD Return

UPR.IR
28.94%
ISEQ All Share (^ISEQ)
3.46%

1-Year Return

UPR.IR
5.88%
ISEQ All Share (^ISEQ)
2.30%

3-Year Return

UPR.IR
29.34%
ISEQ All Share (^ISEQ)
38.78%

5-Year Return

UPR.IR
116.63%
ISEQ All Share (^ISEQ)
90.52%

Compare To: UPR.IR

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: UPR.IR

View More

Valuation Measures

Annual
As of 4/16/2025
  • Market Cap

    723.95M

  • Enterprise Value

    1.03B

  • Trailing P/E

    11.87

  • Forward P/E

    12.63

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.27

  • Price/Book (mrq)

    1.80

  • Enterprise Value/Revenue

    0.37

  • Enterprise Value/EBITDA

    7.53

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.32%

  • Return on Assets (ttm)

    4.04%

  • Return on Equity (ttm)

    17.47%

  • Revenue (ttm)

    2.77B

  • Net Income Avi to Common (ttm)

    64.2M

  • Diluted EPS (ttm)

    0.2400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    102.99M

  • Total Debt/Equity (mrq)

    101.06%

  • Levered Free Cash Flow (ttm)

    5.83M

Research Analysis: UPR.IR

View More

Company Insights: UPR.IR

Research Reports: UPR.IR

View More

People Also Watch